ESS/MAX IV Summit 2024

Program

Registration opens 8.00.

9.00 Welcome!

• Darja Isaksson, Director General, Vinnova
• Katarina Bjelke, Director General, Swedish Research Council

9.15 Mölnlycke Health Care AB & GoCo Health Innovation City

• Zlatko Rihter, CEO, Mölnlycke Healt Care AB
• Jacob Torell, VD Steptura

9.30 The future Life Sciences and MedTech in Sweden

Are the tools and techniques offered by ESS and MAX IV relevant to the researchers? What more could MAX IV and ESS do to meet the needs?

• Zlatko Rihter, CEO, Mölnlycke Health Care AB
• Fredrik Wessberg, CEO CCRM Nordic
• Hanna Barriga, Research specialist, SciLifeLab

10.15 MAX IV at a glance

• Olof Karis, Director, MAX IV

10.30 Coffee break

11.00 Big science – a tool for making Sweden even better?

Deep-tech, AI, bioprinting, Nano technology, internet of medical things. The developers of drugs, therapies and personalized medicine, and medtech are using all the new techniques and tools. How does big research infrastructures like ESS and MAX IV fit in? How to incorporate new techniques and tools to be even more successful?

• Erik Lindahl, Professor of Biophysics, Stockholm University
• Marianna Yanez Arteta, Associate Director at the Advanced Drug Delivery division within Pharmaceutical Sciences in AstraZeneca
• Federica Sebastiani, Tenure Track Assistant Professor, Copenhagen University
• Chris Schlenk, Group Vice President, Wellspect Healthcare

11.45 ESS at a glance

• Helmut Schober, Director General, ESS

12.00 Lunch break including workshop

During lunch the participants will discuss these questions:

• How do you envision your future use of ESS or MAX IV, i.e. what should the facilities provide to be relevant for you?
• What do you lack to be able to conduct research or R&D at a large-scale research facility?
  #essmaxivsummit

13.45 Workshop summary and discussion

14.15 Education, labs, data analysis – who provides what?

Several bottlenecks are slowing down the utility of large-scale research infrastructures, which is bad for science and poor return on investment. Alas, those bottlenecks need to be removed. In this panel we will discuss what needs to change and who should make the change.

• Pia Kinhult, Head of Host States Relations, ESS
• Oliver Billker, Director, The laboratory for Molecular Infection Medicine Sweden
• Selma Maric, Director, ARI4Sweden
• Anders Bjorholm Dahl, Head of QIM Center

15.00 The conditions for Life Science research in Sweden

How does the Swedish government think, which countries are good role models and why, what does the review of the life science strategy and the upcoming research and innovation bill entail?

• Mats Persson, Minister for Education

15.30 Summary

• Darja Isaksson, Director General, Vinnova
• Katarina Bjelke, Director General, Swedish Research Council

16.00–17.00 Mingle opportunity

After we finish the Summit, you can mingle with old and new acquaintances at Vigor & Joy inside the GoCo House